Basic Science and Pathogenesis

Area of Science:

• Neuroscience
• Pharmacology
• Genetics

Background:

• Alzheimer's disease (AD) significantly contributes to neuropsychiatric disorders, with social behavioral impairments posing diagnostic and therapeutic challenges.
• Anterior cingulate cortex (ACC) dysfunction is a key factor in AD-related behavioral deficits.
• Endocannabinoids regulate synaptic plasticity in the ACC, but their role in AD pathology is unclear.

Purpose of the Study:

• To investigate the role of synaptic endocannabinoid signaling in the ACC in Alzheimer's disease (AD).
• To understand how endocannabinoid signaling alterations contribute to synaptic homeostasis and social behavior deficits in AD.
• To explore therapeutic strategies targeting endocannabinoid signaling for AD-induced social behavioral impairments.

Main Methods:

• Utilized optogenetics, electrophysiology, pharmacology, and behavioral techniques.
• Characterized presynaptic CB1 receptors and endocannabinoid synthesis alterations during AD progression.
• Employed calcium signal recording and pharmacological interventions to assess synaptic homeostasis.

Main Results:

• Cannabinoid signaling regulates synaptic transmission at pre- and post-synaptic terminals in the ACC during AD.
• Disrupted endocannabinoid signaling impacts synaptic homeostasis, particularly in socially isolated mice, exacerbating AD deficits.
• Targeting synaptic endocannabinoid signaling shows potential for mitigating AD-induced social behavioral deficits.

Conclusions:

• AD pathology is intricately linked to synaptic endocannabinoid signaling and social behavior alterations.
• Unraveled molecular, cellular, and behavioral correlates of AD-induced cannabinoid signaling changes.
• Provides a foundation for novel therapeutic approaches for AD-related neuropsychiatric disorders.